Pileggi Claudia, Caligiuri Emilia, Nobile Carmelo G A, Pavia Maria
Department of Health Sciences, University of Catanzaro "Magna Græcia", Via Tommaso Campanella, 88100, Catanzaro, Italy.
Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende, 87036, Cosenza, Italy.
BMC Health Serv Res. 2018 Feb 12;18(1):105. doi: 10.1186/s12913-018-2895-2.
Hospital stay represents the opportunity for a change of therapy, about which patients may not know indications, contraindications, and mode of administration, which may lead to dosing errors, drug interactions, side effects, etc. It is therefore vital to communicate appropriate information to the discharged patient with a new prescription drug. The purpose of the study was to evaluate: 1) how communication about new chronic therapies is managed at hospital discharge and what kind of information is provided to patients; 2) to what extent patients are aware and confident in the management of these medications; 3) whether the way communication is provided affects patients' awareness and self-confidence in the management of these therapies.
Participants were adult patients who were prescribed at least one new chronic medication at hospital discharge. A telephone interview after hospital discharge was performed to assess whether or not hospital healthcare personnel had given information about prescribed therapies and which aspects of therapies had been object of information.
Five hundred thirty patients were interviewed. 67.7% reported having received counseling by the hospital physician, while 32.3% by discharge form. Basic information on treatment was provided to the great majority of patients, whereas only few patients reported to have been informed about eventual side effects and related behavior in case of side effects.
Several aspects of patients' knowledge and self-confidence on long term medications prescribed at hospital discharge need to be improved and the way communication is provided has a crucial role in the empowerment of patients in the management of these medications.
住院期间是改变治疗方案的时机,而患者可能并不了解治疗的适应证、禁忌证及给药方式,这可能导致用药错误、药物相互作用、副作用等。因此,向出院患者传达新处方药的适当信息至关重要。本研究的目的是评估:1)出院时如何管理关于新慢性治疗方案的沟通,以及向患者提供何种信息;2)患者对这些药物治疗的了解程度和信心;3)沟通方式是否会影响患者对这些治疗的了解和自我管理信心。
研究对象为出院时至少开具了一种新慢性药物的成年患者。出院后进行电话访谈,以评估医院医护人员是否提供了有关规定治疗方案的信息,以及治疗方案的哪些方面是信息传达的对象。
共访谈了530名患者。67.7%的患者报告接受了医院医生的咨询,32.3%的患者通过出院小结获得了咨询。绝大多数患者获得了关于治疗的基本信息,而只有少数患者报告被告知可能的副作用以及出现副作用时的相关应对措施。
出院时开具的长期用药方面,患者的知识和自我管理信心的多个方面需要改进,沟通方式在增强患者对这些药物的管理能力方面起着关键作用。